We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with buy rank and strong income characteristics for investors to consider today, April 20th:
Rocky Brands, Inc. (RCKY - Free Report) : This manufacturer and marketer of footwear and apparel has witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.5% over the last 60 days.
This Zacks Rank #1 (Strong Buy) company has a dividend yield of 2.82%, compared with the industry average of 1.13%. Its five-year average dividend yield is 2.72%.
Medifast, Inc. (MED - Free Report) : This manufacturer and distributor of weight loss, weight management, healthy living products, and other consumable health and nutritional products has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.8% over the last 60 days.
This Zacks Rank #2 (Buy) company has a dividend yield of 6.98%, compared with the industry average of 0.34%. Its five-year average dividend yield is 2.34%.
General Mills, Inc. (GIS - Free Report) : This manufacturer and marketer of branded consumer foods has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.7% over the last 60 days.
This Zacks Rank #2 (Buy) company has a dividend yield of 3.23%, compared with the industry average of 0.34%. Its five-year average dividend yield is 3.57%.
Fluor Corporation (FLR - Free Report) : This provider of engineering, procurement, construction, fabrication and modularization, operation, maintenance and asset integrity, and project management services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.3% over the last 60 days.
This Zacks Rank #2 (Buy) company has a dividend yield of 4.87%, compared with the industry average of 0.00%. Its five-year average dividend yield is 2.12%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Top Ranked Income Stocks to Buy for April 20th
Here are four stocks with buy rank and strong income characteristics for investors to consider today, April 20th:
Rocky Brands, Inc. (RCKY - Free Report) : This manufacturer and marketer of footwear and apparel has witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.5% over the last 60 days.
Rocky Brands, Inc. Price and Consensus
Rocky Brands, Inc. price-consensus-chart | Rocky Brands, Inc. Quote
This Zacks Rank #1 (Strong Buy) company has a dividend yield of 2.82%, compared with the industry average of 1.13%. Its five-year average dividend yield is 2.72%.
Rocky Brands, Inc. Dividend Yield (TTM)
Rocky Brands, Inc. dividend-yield-ttm | Rocky Brands, Inc. Quote
Medifast, Inc. (MED - Free Report) : This manufacturer and distributor of weight loss, weight management, healthy living products, and other consumable health and nutritional products has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.8% over the last 60 days.
MEDIFAST INC Price and Consensus
MEDIFAST INC price-consensus-chart | MEDIFAST INC Quote
This Zacks Rank #2 (Buy) company has a dividend yield of 6.98%, compared with the industry average of 0.34%. Its five-year average dividend yield is 2.34%.
MEDIFAST INC Dividend Yield (TTM)
MEDIFAST INC dividend-yield-ttm | MEDIFAST INC Quote
General Mills, Inc. (GIS - Free Report) : This manufacturer and marketer of branded consumer foods has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.7% over the last 60 days.
General Mills, Inc. Price and Consensus
General Mills, Inc. price-consensus-chart | General Mills, Inc. Quote
This Zacks Rank #2 (Buy) company has a dividend yield of 3.23%, compared with the industry average of 0.34%. Its five-year average dividend yield is 3.57%.
General Mills, Inc. Dividend Yield (TTM)
General Mills, Inc. dividend-yield-ttm | General Mills, Inc. Quote
Fluor Corporation (FLR - Free Report) : This provider of engineering, procurement, construction, fabrication and modularization, operation, maintenance and asset integrity, and project management services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.3% over the last 60 days.
Fluor Corporation Price and Consensus
Fluor Corporation price-consensus-chart | Fluor Corporation Quote
This Zacks Rank #2 (Buy) company has a dividend yield of 4.87%, compared with the industry average of 0.00%. Its five-year average dividend yield is 2.12%.
Fluor Corporation Dividend Yield (TTM)
Fluor Corporation dividend-yield-ttm | Fluor Corporation Quote
See the full list of top ranked stocks here.
Find more top income stocks with some of our great premium screens.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>